Clinical evaluation of soluble cytokeratin 19 fragments (cyfra 21-1) in serum and urine of patients with bladder cancer
- 30 November 1996
- Vol. 48 (5) , 703-710
- https://doi.org/10.1016/s0090-4295(96)00253-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Comparison of Cyfra 21–1, Tpa and Tps in Lung Cancer, Urinary Bladder Cancer and Benign DiseasesThe International Journal of Biological Markers, 1994
- CYFRA 21-1: A new marker in lung cancerCancer, 1993
- Cytokeratin Shedding in Urine as a Biological Marker for Bladder Cancer: Monoclonal Antibody-Based EvaluationBritish Journal of Urology, 1991
- Correlation of DNA Ploidy Levels with Altered Cytokeratin Patterns in Rat Bladder TumorsPathobiology, 1991
- Correlation of Cytokeratin Patterns with Histopathology during Neoplastic Progression in the Rat Urinary BladderPathobiology, 1990
- Diversity in immunoreactivity of tumor-derived cytokeratin monoclonal antibodies.Journal of Histochemistry & Cytochemistry, 1989
- MOLECULAR AND CELLULAR BIOLOGY OF INTERMEDIATE FILAMENTSAnnual Review of Biochemistry, 1988
- Monoclonal anti-cytokeratin antibody from a hybridoma clone generated by electrofusionEuropean Journal of Cancer and Clinical Oncology, 1985
- The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cellsPublished by Elsevier ,1982
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981